Epitalon vs GHK-Cu
Reviewed by the BestHealingPeptides Editorial Team ·
Epitalon and GHK-Cu are both grouped under 'anti-aging' peptide research but address different biological axes. Epitalon is a synthetic tetrapeptide studied for telomerase upregulation and pineal-related effects; GHK-Cu is a naturally occurring copper-binding tripeptide with the deepest dermal regenerative evidence base of any non-prescription peptide ingredient.
Epitalon
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modelled on the bovine pineal extract epithalamin. Investigated primarily in Russian gerontology research for effects on telomerase activity in cultured somatic cells, circadian rhythm normalisation in aged animals, and antioxidant defence. Evidence is largely confined to one research network and independent replication is limited.
GHK-Cu
A naturally occurring copper-binding tripeptide (Gly-His-Lys) complexed with Cu(II). Extensively studied in dermatology for wound healing, collagen synthesis, antioxidant defence, and hair-follicle stimulation.
| Aspect | Epitalon | GHK-Cu |
|---|---|---|
| Size | 4 amino acids (~390 Da) | 3 amino acids (~402 Da with Cu) |
| Lead mechanism | Telomerase (hTERT) upregulation in cultured fibroblasts | Copper delivery to lysyl oxidase + broad fibroblast transcriptional remodelling |
| Evidence breadth | Limited; Khavinson group dominates | Substantial; five decades + multi-laboratory |
| Independent replication | Limited (concentration concern) | Strong across mechanism, dermal, and gene-expression streams |
| UK status | Research-chemical only | Legal cosmetic ingredient + research-chemical |
| Route | Subcutaneous injection (research) | Topical (cosmetic + research); injectable (research) |
What 'anti-aging' means for each
GHK-Cu addresses the visible, tissue-level consequences of skin ageing — declining dermal collagen and elastin, impaired angiogenesis at the dermal microvasculature, reduced antioxidant defence, and the chronic low-grade inflammation that drives photoageing. Its mechanism is concrete and reproducible at the cellular level: copper delivery to lysyl oxidase, broad transcriptional remodelling in human dermal fibroblasts, SOD activation, and TGF-β1 suppression. Epitalon addresses cellular-ageing biology at the level of the chromosome: telomerase upregulation in cultured fibroblasts (Khavinson et al., 2003), reported effects on pineal function, and broader claims about cellular replicative capacity. The two are therefore studied for different tissue-versus-systemic endpoints.
Evidence depth and quality
GHK-Cu has by far the larger and more methodologically diverse evidence base. Five decades of research since Pickart's 1973 discovery have generated dermatological, wound-healing, hair-follicle, anti-fibrotic, and gene-expression datasets across multiple laboratories. Epitalon's evidence is largely confined to the Khavinson-led St Petersburg research network and Russian-language literature, with limited independent replication in Western laboratories. This sourcing-concentration limitation is the principal weakness of the epitalon evidence base — the underlying hypotheses are interesting, but a small number of investigators dominate the published record.
Delivery and use
GHK-Cu is widely used as a topical cosmetic ingredient at concentrations of 0.05–0.5% in marketed UK formulations, and research-grade material is also studied at nanomolar concentrations in vitro and as a topical preparation in vivo. Its INCI name 'Copper Tripeptide-1' carries a legal UK cosmetic-ingredient status under the UK Cosmetic Products Regulation. Epitalon is typically administered by subcutaneous injection in research models; no equivalent cosmetic or licensed use exists. Epitalon's research-chemical availability is broad but the evidence base does not justify routine topical use.
Regulatory and safety
GHK-Cu has an extensive cosmetic-grade safety record at typical formulation concentrations, with rare contact sensitisation as the only commonly reported adverse effect. Systemic and injectable safety data are more limited and require pilot dose-ranging in any animal study. Epitalon has been used in elderly populations in Russian clinical work without published serious adverse events, but the dataset is small relative to GHK-Cu's cosmetic-use record. Neither is licensed as a medicine by the MHRA.
Choosing between them
Choose GHK-Cu for any research question targeting dermal regenerative biology, wound healing, collagen and elastin synthesis, or topical anti-ageing endpoints. Choose epitalon only where the research hypothesis specifically targets telomerase, replicative-capacity, or pineal-function endpoints, and where the limitation of single-network sourcing is acknowledged in study design. Combining the two in a research stack is biologically plausible (different mechanistic axes, no known interactions) and is the basis of some anti-ageing skin research protocols.
Verdict
GHK-Cu has the substantially deeper and more independently replicated anti-ageing research base. Epitalon's telomerase-axis research interest is legitimate but methodologically narrower. For dermal anti-ageing research, GHK-Cu is the default; for cellular-replicative-capacity research where the hypothesis specifically requires telomerase upregulation, epitalon adds a complementary mechanism.
Where to source research peptides for laboratory research
The following UK-based suppliers stock research-grade, lyophilised peptides for in-vitro and pre-clinical work. Purity and provenance vary; always request a Certificate of Analysis (CoA) and confirm cold-chain storage on arrival. None of the products linked below are approved for human use.
- PeptideAuthority.co.uk
UK-based research peptide supplier with batch certificates of analysis and >99% purity testing.
- PeptideBarn.co.uk
Wide catalogue of research-grade lyophilised peptides shipped from the UK, including bulk vials.